Spine Services
Driving faster, smarter decisions across competitive intelligence, forecasting, and strategic initiatives. Global coverage: US, EU, UK, Japan, China, Australia, Canada & RoW.
Spine Services is an AI-enabled strategic intelligence firm focused on life sciences, helping organizations make faster, smarter decisions across competitive intelligence, forecasting, and scientific support.
The spine is the body’s silent powerhouse — providing structure, enabling movement, maintaining balance, and absorbing pressure. That’s exactly how we operate. With our deep experience, we act as the backbone of your organization — supporting complex workloads, enabling seamless cross-functional collaboration, and driving informed decision-making across the drug development lifecycle. We bring agility to evolving priorities, stability to execution, and resilience during uncertainty. And like the spine, despite playing a critical role, we remain behind the scenes — strengthening the organization, enhancing its value, and enabling it to perform at its best.
AI-enabled workflows accelerate data mining, synthesis, and reporting, while human expertise ensures quality, interpretation, and strategic insights.
Speed of AI. Judgment of experts.
Built on experience within global pharma-grade data security, compliance, and governance frameworks.
NDA-driven engagements, secure environments, and strict data handling protocols.
"Spine Services supported us with CI landscapes and monitoring, enabling focus on core priorities."
— CEO, Emerging Biotech"Helped shape our external innovation strategy and licensing decisions."
— CSO, Global Pharma
PhD | 16+ years | Competitive Intelligence, Strategy, GCC
PhD in pharmacology with 16 years of experience enabling biopharma decision-making across oncology, metabolic disorders, cardiovascular diseases, Alzheimer’s disease, and global health. Experience spans Novo Nordisk, GSK, and SmartAnalyst (Putnam), working at the intersection of R&D, competitive intelligence, and strategy. Known for translating complex clinical, scientific, and market signals into clear portfolio direction and investment decisions. Also brings experience in building and scaling Global Capability Centers (GCC) and contributes as a Certified Independent Director.
18+ years | CI, Forecasting, Market Analytics
Life sciences consulting professional with 18 years of experience supporting pharmaceutical and biotech clients across strategy, analytics, and commercial decision-making. Deep expertise in oncology, immunology, and rare diseases, with a strong track record in market assessment, competitive intelligence, forecasting, and pipeline analytics. Has led high-impact engagements and teams, delivering insights that drive asset prioritization and portfolio strategy. Experience includes SmartAnalyst (INIZIO Group), and WNS Analytics.